Pharma-Bio Serv, Inc. (PBSV)

Pharma-Bio Serv Cash Flow Statement

Financials in millions USD. Fiscal year is November - October.

Year	2023	2022	2021	2020	2019
Net Income	1.31	1.01	-2.09	2.05	2.09
Depreciation & Amortization	0.19	0.05	0.07	0.09	0.1
Share-Based Compensation	0.05	0.07	0.06	0.04	0.03
Other Operating Activities	0.34	-0.54	2.77	-0.65	-4.43
Operating Cash Flow	1.89	0.59	0.8	1.53	-2.21
Operating Cash Flow Growth	219.17%	-26.39%	-47.24%	-	-
Capital Expenditures	-0.01	-0.02	-0.01	-0.06	-0.06
Acquisitions	0	0	0.06	0.03	0.1
Change in Investments	-4.21	-	-	-	-0.14
Other Investing Activities	-	-	1.25	-	1.94
Investing Cash Flow	-4.22	-0.02	1.3	-0.03	1.84
Dividends Paid	-1.72	-3.45	-1.73	-1.73	0
Share Repurchases	-0.03	-0.08	-0.03	-0	-0.09
Other Financing Activities	-0.07	-0.16	-0.05	1.92	-0.24
Financing Cash Flow	-1.76	-3.53	-1.75	0.19	-0.16
Net Cash Flow	-4.02	-3.01	0.33	1.65	-0.54
Free Cash Flow	1.88	0.57	0.79	1.47	-2.27
Free Cash Flow Growth	228.64%	-27.81%	-45.98%	-	-
Free Cash Flow Margin	11.10%	2.95%	3.95%	6.82%	-11.61%
Free Cash Flow Per Share	0.08	0.02	0.03	0.06	-0.10

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.